EU
EU votes for tighter internet drug regulations
May 4, 2010Sales and Marketing EU, counterfeits, viagra
The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …
European regulators begin Tysabri review
October 26, 2009Sales and Marketing EU, Tysabri, reg
European regulators have begun a risk-benefit review of Biogen Idec’s multiple sclerosis drug Tysabri, which has been linked to 23 …
EFPIA starts anti-counterfeiting pilots in Sweden
October 21, 2009Manufacturing and Production, Sales and Marketing EU, counterfeits, supply chain
More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …
European pharma companies raided
October 7, 2009Sales and Marketing EU, reg
Several pharma companies have been raided as part of ongoing European Commission investigations into competitiveness issues. Sanofi-Aventis, Novartis and generic …
Europe warns pharma about further competition probes
October 1, 2009Sales and Marketing EU, antitrust investigation, reg
The European Commission has warned the industry a new round of antitrust probes will be coming soon, just as the …
Europe approves two swine-flu vaccines
September 30, 2009Sales and Marketing EU, GSK, Novartis, h1n1
The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …
Safety First
September 22, 2009Research and Development, Sales and Marketing EU, US, reg, safety
A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
End of the line for European paracetamol
January 12, 2009Manufacturing and Production EU
The last European plant manufacturing paracetamol closed for the final time at the turn of the year, another sign that …
The Pharmafocus Interview: Elmar Schnee
January 6, 2009Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …
Abraxis Biosciences launches Abraxane in Europe
January 2, 2009Sales and Marketing Abraxis, Cancer, EU
US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …
Commission to reveal anti-competitive probe findings
November 27, 2008Sales and Marketing EU, reg
The European pharmaceutical industry could shortly face a major inquiry into its practices, with the European Commission ready to reveal …
Latest content
